The University of Southampton
University of Southampton Institutional Repository

Fracture risk prediction using the fracture risk assessment tool in individuals with cancer

Fracture risk prediction using the fracture risk assessment tool in individuals with cancer
Fracture risk prediction using the fracture risk assessment tool in individuals with cancer

Importance: the Fracture Risk Assessment Tool (FRAX) is a fracture risk prediction tool for 10-year probability of major osteoporotic fracture (MOF) and hip fracture in the general population. Whether FRAX is useful in individuals with cancer is uncertain. 

Objective: to determine the performance of FRAX for predicting incident fractures in individuals with cancer. 

Design, setting, and participants: this retrospective population-based cohort study included residents of Manitoba, Canada, with and without cancer diagnoses from 1987 to 2014. Diagnoses were identified through the Manitoba Cancer Registry. Incident fractures to March 31, 2021, were identified in population-based health care data. Data analysis occurred between January and March 2023. 

Main outcomes and measures: FRAX scores were computed for those with bone mineral density (BMD) results that were recorded in the Manitoba BMD Registry. 

Results: this study included 9877 individuals with cancer (mean [SD] age, 67.1 [11.2] years; 8693 [88.0%] female) and 45877 individuals in the noncancer cohort (mean [SD] age, 66.2 [10.2] years; 41656 [90.8%] female). Compared to individuals without cancer, those with cancer had higher rates of incident MOF (14.5 vs 12.9 per 1000 person-years; P <.001) and hip fracture (4.2 vs 3.5 per 1000 person-years; P =.002). In the cancer cohort, FRAX with BMD results were associated with incident MOF (HR per SD increase, 1.84 [95% CI, 1.74-1.95]) and hip fracture (HR per SD increase, 3.61 [95% CI, 3.13-4.15]). In the cancer cohort, calibration slopes for FRAX with BMD were 1.03 for MOFs and 0.97 for hip fractures. 

Conclusions and relevance: in this retrospective cohort study, FRAX with BMD showed good stratification and calibration for predicting incident fractures in patients with cancer. These results suggest that FRAX with BMD can be a reliable tool for predicting incident fractures in individuals with cancer.

2374-2437
1554-1560
Ye, Carrie
dfb1a82d-2163-41f1-8c3b-d93267a0a1d0
Leslie, William D.
5b2dd5d6-4569-40a3-a9b1-95152d11e4f1
Al-Azazi, Saeed
5c964386-aaeb-4496-9764-6701d1e2366a
Yan, Lin
4065ffb6-49ad-45b8-be72-72013cbc3d9b
Lix, Lisa M.
2fb61783-047d-4a4b-a45d-e09ac0763a7b
Czaykowski, Piotr
71d841fb-cf45-47cd-86b3-d267b44361f5
McCloskey, Eugene V.
2f057a16-3d4e-4597-80c7-6ce47f969c78
Johansson, Helena
04f12338-4dd1-437b-b9bc-e0884130c215
Harvey, Nicholas C.
ce487fb4-d360-4aac-9d17-9466d6cba145
Kanis, John A.
f1621d8d-8afb-4d97-9679-2165d88a344d
Singh, Harminder
26d89ac0-eb86-41c5-8525-4d3f3dedb284
Ye, Carrie
dfb1a82d-2163-41f1-8c3b-d93267a0a1d0
Leslie, William D.
5b2dd5d6-4569-40a3-a9b1-95152d11e4f1
Al-Azazi, Saeed
5c964386-aaeb-4496-9764-6701d1e2366a
Yan, Lin
4065ffb6-49ad-45b8-be72-72013cbc3d9b
Lix, Lisa M.
2fb61783-047d-4a4b-a45d-e09ac0763a7b
Czaykowski, Piotr
71d841fb-cf45-47cd-86b3-d267b44361f5
McCloskey, Eugene V.
2f057a16-3d4e-4597-80c7-6ce47f969c78
Johansson, Helena
04f12338-4dd1-437b-b9bc-e0884130c215
Harvey, Nicholas C.
ce487fb4-d360-4aac-9d17-9466d6cba145
Kanis, John A.
f1621d8d-8afb-4d97-9679-2165d88a344d
Singh, Harminder
26d89ac0-eb86-41c5-8525-4d3f3dedb284

Ye, Carrie, Leslie, William D., Al-Azazi, Saeed, Yan, Lin, Lix, Lisa M., Czaykowski, Piotr, McCloskey, Eugene V., Johansson, Helena, Harvey, Nicholas C., Kanis, John A. and Singh, Harminder (2024) Fracture risk prediction using the fracture risk assessment tool in individuals with cancer. JAMA Oncology, 10 (11), 1554-1560. (doi:10.1001/jamaoncol.2024.4318).

Record type: Article

Abstract

Importance: the Fracture Risk Assessment Tool (FRAX) is a fracture risk prediction tool for 10-year probability of major osteoporotic fracture (MOF) and hip fracture in the general population. Whether FRAX is useful in individuals with cancer is uncertain. 

Objective: to determine the performance of FRAX for predicting incident fractures in individuals with cancer. 

Design, setting, and participants: this retrospective population-based cohort study included residents of Manitoba, Canada, with and without cancer diagnoses from 1987 to 2014. Diagnoses were identified through the Manitoba Cancer Registry. Incident fractures to March 31, 2021, were identified in population-based health care data. Data analysis occurred between January and March 2023. 

Main outcomes and measures: FRAX scores were computed for those with bone mineral density (BMD) results that were recorded in the Manitoba BMD Registry. 

Results: this study included 9877 individuals with cancer (mean [SD] age, 67.1 [11.2] years; 8693 [88.0%] female) and 45877 individuals in the noncancer cohort (mean [SD] age, 66.2 [10.2] years; 41656 [90.8%] female). Compared to individuals without cancer, those with cancer had higher rates of incident MOF (14.5 vs 12.9 per 1000 person-years; P <.001) and hip fracture (4.2 vs 3.5 per 1000 person-years; P =.002). In the cancer cohort, FRAX with BMD results were associated with incident MOF (HR per SD increase, 1.84 [95% CI, 1.74-1.95]) and hip fracture (HR per SD increase, 3.61 [95% CI, 3.13-4.15]). In the cancer cohort, calibration slopes for FRAX with BMD were 1.03 for MOFs and 0.97 for hip fractures. 

Conclusions and relevance: in this retrospective cohort study, FRAX with BMD showed good stratification and calibration for predicting incident fractures in patients with cancer. These results suggest that FRAX with BMD can be a reliable tool for predicting incident fractures in individuals with cancer.

Text
JAMA Oncology Cancer FRAX Manuscript 2nd REVISION-clean (1) - Accepted Manuscript
Download (43kB)

More information

e-pub ahead of print date: 3 October 2024

Identifiers

Local EPrints ID: 496844
URI: http://eprints.soton.ac.uk/id/eprint/496844
ISSN: 2374-2437
PURE UUID: 0b3ed757-41be-4a5e-86bd-7ddf25f7b90b
ORCID for Nicholas C. Harvey: ORCID iD orcid.org/0000-0002-8194-2512

Catalogue record

Date deposited: 08 Jan 2025 08:19
Last modified: 10 Jan 2025 02:42

Export record

Altmetrics

Contributors

Author: Carrie Ye
Author: William D. Leslie
Author: Saeed Al-Azazi
Author: Lin Yan
Author: Lisa M. Lix
Author: Piotr Czaykowski
Author: Eugene V. McCloskey
Author: Helena Johansson
Author: John A. Kanis
Author: Harminder Singh

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×